高BMI是接受美沙治疗的患者药物相关死亡的特定风险因素:一项病例对照研究
Thikra Algahtani1, Tom Le Ruez2, John Strang3,4
1Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, King's College London, London, UK.
Addiction (Abingdon, England)
|February 13, 2025
概括
超出健康范围的体重指数 (BMI) 的阿片类激素治疗 (OAT) 患者面临更高的死亡风险. 这包括体重不足和超重的个体,突出了OAT中体重管理的必要性.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
- 临床研究 临床研究
背景情况:
- 针对阿片类药物依赖的阿片类激素治疗 (OAT),特别是甲,与显著的体重增加有关.
- 肥胖是OAT患者群体中日益关注的问题,需要对其健康影响进行调查.
研究的目的:
- 为了确定超重的OAT患者 (BMI ≥25) 是否有高死亡风险.
- 探索BMI极端 (体重不足和超重) 与OAT患者的死亡风险之间的关系.
主要方法:
- 一个回顾性病例控制研究,利用来自英国OAT服务的匿名数据.
- 收集的数据包括身高,体重,年龄,性别,OAT类型/剂量,吸烟状态和邮政编码.
- 调整后的回归模型用于计算死亡风险调整后的几率比率 (aOR) 和95%置信区间 (95% CI).
主要成果:
- 研究群体的平均BMI (25.75) 超过了健康体重值,死亡个体的BMI更高.
- 增加的BMI与更高的死亡风险相关:BMI 30 (7.7%),BMI 35 (37.2%),BMI 40 (107.3%). 这两种类型的BMI均有相关性.
- 体重不足的人 (BMI 15) 也面临死亡风险增加 (43.6%). 高龄,吸烟,生活在贫困地区,以及甲处方 (与布诺啡因对比) 与较高的死亡率有关.
结论:
- 在健康范围之外的BMI的OAT患者表现出死亡风险增加.
- 体重不足和超重/肥胖的BMI都与这一群体的死亡率增加有关.
- 应考虑体重管理作为OAT患者综合护理的一部分.
相关概念视频
Obesity
366
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
366
Pulmonary Tuberculosis I
218
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
218
Factors Affecting Drug Biotransformation: Biological
99
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
99
Overview of Lipid Metabolism
952
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
952
Hepatic Drug Excretion: Influencing Factors
78
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
78
Bulimia Nervosa
46
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
46


